Optimal management of patients receiving cabazitaxel-based chemotherapy

about

Chemotherapy for prostate cancer: Clinical practice in Canada.Metastatic castration-resistant prostate cancer: The emerging continuum of care.

P2860

Q36838375-A5C75047-6AE0-48F1-AAF5-1BFF9D0FF015 Q36838381-469783D1-314C-4B8E-95BF-E1317F78D1BB

P2860

Optimal management of patients receiving cabazitaxel-based chemotherapy

Item

http://www.wikidata.org/entity/Q36838378

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Optimal management of patients receiving cabazitaxel-based chemotherapy

@en

type

Item

label

Optimal management of patients receiving cabazitaxel-based chemotherapy

@en

prefLabel

Optimal management of patients receiving cabazitaxel-based chemotherapy

@en

P1476

Optimal management of patients receiving cabazitaxel-based chemotherapy

@en

P2093

Catherine Sperlich

http://www.w3.org/2001/XMLSchema#string

Fred Saad

http://www.w3.org/2001/XMLSchema#string

P2860

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Abiraterone and increased survival in metastatic prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Guidelines for the management of castrate-resistant prostate cancer.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Extravasation of systemic hemato-oncological therapies.

Chemotherapy for prostate cancer: Clinical practice in Canada.

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.

Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice.

Cabazitaxel in prostate cancer: stretching a string.

P304

S18-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5489/CUAJ.275

http://www.w3.org/2001/XMLSchema#string

P433

1-2 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23682302

http://www.w3.org/2001/XMLSchema#string

P932

3652212

http://www.w3.org/2001/XMLSchema#string

Optimal management of patients receiving cabazitaxel-based chemotherapy

about

P2860

P2860

Optimal management of patients receiving cabazitaxel-based chemotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932